Aduro BioTech is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies.
Aduro Biotech is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies that are designed to harness the body's natural immune system for the treatment of patients with challenging diseases.It was founded in 2000 and headquartered in Berkeley, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 5, 2015 | Series D | $51.40M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Franklin Advisors | — | Series D |